Literature DB >> 23282452

Inflammatory bowel disease mucosal biopsies have specialized lymphokine mRNA profiles.

G E Mullin1, Z R Maycon, L Braun-Elwert, R Cerchia, S P James, S Katz, G S Weissman, M J McKinley, S E Fisher.   

Abstract

: Crohn's disease (CD) and ulcerative colitis (UC) are idiopathic inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and are associated with abnormalities of peripheral and mucosal immune function. The aim of our study was to determine whether CD or UC is characterized by discrete profiles of intestinal lymphokine production. Total cellular RNA was isolated from biopsies of healthy controls and from patients with IBD. Messenger RNA transcript levels in biopsies were determined for interleukin-2 (IL-2), IL-4, IL-5, and interferon-γ (IFN-γ), using a quantitative reverse transcriptase polymerase chain reaction method. Compared with inflamed UC mucosa and controls, CD mucosal lesions contained higher IL-2 and IFN-γ mRNA (p < 0.05), which is consistent with a T-helper cell 1 (Th1)-like pattern. In UC, IL-5 mRNA content was higher in involved areas compared with controls (p < 0.05) and inflamed CD lesions (p < 0.05), suggestive of a Th2 pattern. We conclude that the intestinal mucosa of CD and UC have inflammatory responses characterized by discrete T-helper profiles of lymphokines. This strongly suggests that the immunopathogenesis of these two forms of IBD are different.

Entities:  

Year:  1996        PMID: 23282452

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  10 in total

1.  Enhanced production of IL-8 in chronic but not in early ileal lesions of Crohn's disease (CD).

Authors:  E Brandt; J F Colombel; N Ectors; L Gambiez; D Emilie; K Geboes; M Capron; P Desreumaux
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease.

Authors:  C Gasche; S Bakos; C Dejaco; W Tillinger; S Zakeri; W Reinisch
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

3.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

4.  Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease.

Authors:  Howard A Kader; Velizar T Tchernev; Ebenezer Satyaraj; Serguei Lejnine; Gregory Kotler; Stephen F Kingsmore; Dhavalkumar D Patel
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

5.  Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.

Authors:  L A Dieleman; M J Palmen; H Akol; E Bloemena; A S Peña; S G Meuwissen; E P Van Rees
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

Review 6.  The Role of T-Cell Subsets in Chronic Inflammation in Celiac Disease and Inflammatory Bowel Disease Patients: More Common Mechanisms or More Differences?

Authors:  Tadakazu Hisamatsu; Ulrike Erben; Anja A Kühl
Journal:  Inflamm Intest Dis       Date:  2016-04-09

Review 7.  Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease.

Authors:  Eirini Giannoudaki; Siobhan Gargan; Seamus Hussey; Aideen Long; Patrick T Walsh
Journal:  Front Pediatr       Date:  2021-03-18       Impact factor: 3.418

8.  Importance of eosinophilic infiltration of the colonic mucosa in ulcerative colitis patients who are refractory to maintenance therapy: A prospective, single-center study.

Authors:  Takahiro Miyazu; Natsuki Ishida; Yusuke Asai; Satoshi Tamura; Shinya Tani; Mihoko Yamade; Yasushi Hamaya; Moriya Iwaizumi; Satoshi Osawa; Takahisa Furuta; Satoshi Baba; Ken Sugimoto
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

9.  Mucosal Interleukin-10 depletion in steroid-refractory Crohn's disease patients.

Authors:  Anna Carrasco; Eva Tristán; Fernando Fernández-Bañares; Albert Martín-Cardona; Montserrat Aceituno; Yamile Zabana; Lourdes Fluvià; José María Hernández; Violeta Lorén; Josep Manyé; Antonio Salas; Xavier Andújar; Carme Loras; Maria Esteve
Journal:  Immun Inflamm Dis       Date:  2022-10

10.  Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4.

Authors:  M Boirivant; I J Fuss; A Chu; W Strober
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.